Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Heejeong Oh"'
Autor:
Mihyun Bae, Junyeop Daniel Roh, Youjoung Kim, Seong Soon Kim, Hye Min Han, Esther Yang, Hyojin Kang, Suho Lee, Jin Yong Kim, Ryeonghwa Kang, Hwajin Jung, Taesun Yoo, Hyosang Kim, Doyoun Kim, Heejeong Oh, Sungwook Han, Dayeon Kim, Jinju Han, Yong Chul Bae, Hyun Kim, Sunjoo Ahn, Andrew M Chan, Daeyoup Lee, Jin Woo Kim, Eunjoon Kim
Publikováno v:
EMBO Molecular Medicine, Vol 16, Iss 10, Pp 2653-2653 (2024)
Externí odkaz:
https://doaj.org/article/2d03b1ed267d47f38fffedfba864727a
Autor:
Mihyun Bae, Junyeop Daniel Roh, Youjoung Kim, Seong Soon Kim, Hye Min Han, Esther Yang, Hyojin Kang, Suho Lee, Jin Yong Kim, Ryeonghwa Kang, Hwajin Jung, Taesun Yoo, Hyosang Kim, Doyoun Kim, Heejeong Oh, Sungwook Han, Dayeon Kim, Jinju Han, Yong Chul Bae, Hyun Kim, Sunjoo Ahn, Andrew M Chan, Daeyoup Lee, Jin Woo Kim, Eunjoon Kim
Publikováno v:
EMBO Molecular Medicine, Vol 13, Iss 2, Pp 1-27 (2021)
Abstract Glycine transporters (GlyT1 and GlyT2) that regulate levels of brain glycine, an inhibitory neurotransmitter with co‐agonist activity for NMDA receptors (NMDARs), have been considered to be important targets for the treatment of brain diso
Externí odkaz:
https://doaj.org/article/e7bd2f5e0b814f6d81ea04c17922113e
Publikováno v:
Korean Journal of Environmental Agriculture. 39:20-25
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f0fc6728169f1bd0b59a8bae34a0460
https://doi.org/10.5338/kjea.2020.39.1.3
https://doi.org/10.5338/kjea.2020.39.1.3
Autor:
Hyojin Kang, Hwajin Jung, Jin Yong Kim, Daeyoup Lee, Mihyun Bae, Sungwook Han, Taesun Yoo, Hyun Kim, You-Joung Kim, Hyo Sang Kim, Junyeop Daniel Roh, Jin Woo Kim, Suho Lee, Esther Yang, Heejeong Oh, Dayeon Kim, Jinju Han, Hye Min Han, Eunjoon Kim, Doyoun Kim, Yong Chul Bae, Sunjoo Ahn, Ryeonghwa Kang, Andrew K Chan, Seong Soon Kim
Publikováno v:
EMBO Molecular Medicine
EMBO Molecular Medicine, Vol 13, Iss 2, Pp n/a-n/a (2021)
EMBO Molecular Medicine, Vol 13, Iss 2, Pp n/a-n/a (2021)
Glycine transporters (GlyT1 and GlyT2) that regulate levels of brain glycine, an inhibitory neurotransmitter with co‐agonist activity for NMDA receptors (NMDARs), have been considered to be important targets for the treatment of brain disorders wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f315f6239f129b9583c40e18c27c9535
https://pubmed.ncbi.nlm.nih.gov/33428810
https://pubmed.ncbi.nlm.nih.gov/33428810